UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 296

Sortiert nach

NOD SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration

Leukemia, 2004-02, Vol.18 (2), p.341-347

2004

Volltextzugriff (PDF)

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.295-302

2010

Volltextzugriff (PDF)

Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells

Leukemia, 1999-05, Vol.13 (5), p.687-698

1999

Volltextzugriff (PDF)

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes

Annals of oncology, 2007-03, Vol.18 (3), p.535-540

2007

Volltextzugriff (PDF)

Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo

Blood, 1997-05, Vol.89 (9), p.3104-3112

1997

Volltextzugriff (PDF)

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD SCID mice and in NOD SCID mice transgenic for human growth factors

Leukemia, 2003-04, Vol.17 (4), p.760-763

2003

Volltextzugriff (PDF)

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia

Leukemia & lymphoma, 2006-07, Vol.47 (7), p.1245-1252

2006

Volltextzugriff (PDF)

Enhanced Detection, Maintenance, and Differentiation of Primitive Human Hematopoietic Cells in Cultures Containing Murine Fibroblasts Engineered to Produce Human Steel Factor, Interleukin-3, and Granulocyte Colony-Stimulating Factor

Blood, 1996-11, Vol.88 (10), p.3765-3773

1996

Volltextzugriff (PDF)

Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR

Blood, 1998-12, Vol.92 (11), p.4325-4335

1998

Volltextzugriff (PDF)

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2005-11, Vol.36 (9), p.825-830

2005

Volltextzugriff (PDF)

Shifting to outpatient management of acute myeloid leukemia: a prospective experience

Annals of oncology, 2006-05, Vol.17 (5), p.763-768

2006

Volltextzugriff (PDF)

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia

Annals of oncology, 2007-07, Vol.18 (7), p.1246-1252

2007

Volltextzugriff (PDF)

Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias

Leukemia, 2000-04, Vol.14 (4), p.576-585

2000

Volltextzugriff (PDF)

Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML)

Leukemia, 2000-12, Vol.14 (12), p.2135-2141

2000

Volltextzugriff (PDF)

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

Bone marrow transplantation (Basingstoke), 2003-11, Vol.32 (9), p.915-923

2003

Volltextzugriff (PDF)

Self-Renewal of Primitive Human Hematopoietic Cells (Long-Term-Culture-Initiating Cells) in vitro and their Expansion in Defined Medium

Proceedings of the National Academy of Sciences - PNAS, 1996-02, Vol.93 (4), p.1470-1474

1996

Volltextzugriff (PDF)

Differential Expression of Homeobox Genes in Functionally Distinct CD34+Subpopulations of Human Bone Marrow Cells

Proceedings of the National Academy of Sciences - PNAS, 1994-12, Vol.91 (25), p.12223-12227

1994

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

Bone marrow transplantation (Basingstoke), 2000-03, Vol.25 (6), p.605-612

2000

Volltextzugriff (PDF)

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results

Bone marrow transplantation (Basingstoke), 2008-11, Vol.42 (9), p.601-608

2008

Volltextzugriff (PDF)

Diphtheria toxin-interleukin-3 fusion protein (DT IL3) prolongs disease-free survival of leukemic immunocompromised mice

Leukemia, 2003-01, Vol.17 (1), p.155-159

2003

Volltextzugriff (PDF)

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML

Bone marrow transplantation (Basingstoke), 2008-11, Vol.42 (10), p.659-666

2008

Volltextzugriff (PDF)

Characterization of primitive hematopoietic cells in normal human peripheral blood

Blood, 1992-11, Vol.80 (10), p.2513-2521

1992

Volltextzugriff (PDF)

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.1019-1021

2016

Volltextzugriff (PDF)

High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 1998-08, Vol.22 (3), p.259-264

1998

Volltextzugriff (PDF)

High-Dose Cyclophosphamide, Carmustine (BCNU), and Etoposide (VP16-213) With or Without Cisplatin (CBV ± P) and Autologous Transplantation for Patients With Hodgkin's Disease Who Fail to Enter a Complete Remission After Combination Chemotherapy

Blood, 1995-07, Vol.86 (2), p.451-456

1995

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(271)

Publikationsform

Artikel
(267)
Tagungsberichte
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(171)
Humans
(144)
Life Sciences & Biomedicine
(140)
Biological And Medical Sciences
(101)
Hematology
(94)
Female
(90)
Medical Sciences
(81)
Adult
(75)
Male
(73)
Middle Aged
(72)
Oncology
(51)
Aged
(38)
Hematologic And Hematopoietic Diseases
(38)
Animals
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(34)
Mice
(28)
Physical Sciences
(28)
Adolescent
(26)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(26)
Treatment Outcome
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NOD SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes

Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD SCID mice and in NOD SCID mice transgenic for human growth factors

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia

Enhanced Detection, Maintenance, and Differentiation of Primitive Human Hematopoietic Cells in Cultures Containing Murine Fibroblasts Engineered to Produce Human Steel Factor, Interleukin-3, and Granulocyte Colony-Stimulating Factor

Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

Shifting to outpatient management of acute myeloid leukemia: a prospective experience

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia

Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias

Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML)

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

Self-Renewal of Primitive Human Hematopoietic Cells (Long-Term-Culture-Initiating Cells) in vitro and their Expansion in Defined Medium

Differential Expression of Homeobox Genes in Functionally Distinct CD34+Subpopulations of Human Bone Marrow Cells

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results

Diphtheria toxin-interleukin-3 fusion protein (DT IL3) prolongs disease-free survival of leukemic immunocompromised mice

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML

Characterization of primitive hematopoietic cells in normal human peripheral blood

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation

High-Dose Cyclophosphamide, Carmustine (BCNU), and Etoposide (VP16-213) With or Without Cisplatin (CBV ± P) and Autologous Transplantation for Patients With Hodgkin's Disease Who Fail to Enter a Complete Remission After Combination Chemotherapy

Suchergebnisse filtern